Applications open for DayOne Accelerator

The DayOne Accelerator 2026 call for applications is now open! The program supports Swiss and international early-stage healthtech and techbio  startups developing solutions that accelerate pharma R&D.

Program overview:

·       3-month hybrid accelerator based in Basel, Switzerland

·       Access to pharma experts and Basel’s leading life sciences network

·       1:1 mentorship to refine your pharma-specific value proposition

·       Equity-freeand fee-free program

·       Post-program support through DayOne NEXT: up to CHF 50K cash grant, up to CHF 50K services, 12 months office space (conditions apply)

Who should apply:

Early-stage healthtech and techbio startups (Pre-Seed to Series A, <$10M dilutive funding raised) building solutions for pharma R&D and looking to collaborate or partner with pharmaceutical companies.

Join the “Ask Me Anything” webinar on May 7, 16:00–17:00 CET. Register here.

Application deadline: May 31, 2026.